KRAS and neoplasm: Age, sex, energy intake (kcal/d), race/ethnicity; performance status; protocol chemotherapy; primary tumor unresected; diabetes; treatment arm; KRAS status; tumor sidedness; weight change in previous 6 mo; BMI, and physical activity